Trial NCT04598321

View at ClinicalTrials.gov 
Org. Study IDs: BrUOG 390

Last trial update was posted on 2023-10-12

MeSH Interventions

Talazoparib

MeSH Conditions

Carcinoma, Ovarian Epithelial Cystadenocarcinoma, Serous Fallopian Tube Neoplasms Ovarian Neoplasms

Other Conditions

BRCA1 Mutation BRCA2 Mutation Fallopian Tube Cancer High Grade Serous Carcinoma Ovarian Cancer

Stopping Reasons

termination of research grant agreement

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID